Solr Search

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

owing into question the value of traditional post-secondary education. Universities and corporations are being forced to go beyond incremental reforms.

wellness, performance, and longevity. How do we cut through the myths and hype to hone in on approaches that are appropriate and feasible?

and ambitions for making our world a better place, now and in the future.

ly competitive with each other.

companies. Investors want more ROI and consumers are demanding trustworthy content in their Facebook, Twitter, and Snapchat feeds.

ed over the next 55 years.